In another study, M1 and M2 macrophages were classified into seven predominant subgroups according to CD68, CD163, and CD206, in which the CD68+CD163+ TAMs localized in both the tumour nest and stroma, and a higher effective density of this subset in the tumour core correlated with better overall survival and relapse-free survival [78]. Here, CD163 is linked to neoplasm.